Mr. Burgess has an autoimmune disease and chronic pain and was dependent on opioids for several years.
“As the pain got worse and my prescription count increased, I found myself in a very dark place. This is the point where curiosity led to questions, and questions led to alternative approaches. With skepticism aside, I began to research,” he said in a press release. “The results unveiled the fact that prescriptions were no longer needed, and in the process, I began to develop a passion for natural healing. One so strong that it compelled me to leave my career in traditional healthcare of almost 20 years to create this company.”
One CBD donates 1 percent of sales to support opioid addiction treatment, holistic wellness and ecological sustainability.
More articles on leadership and management:
Highmark subsidiary swipes UPMC physician to head up cancer institute
American Well acquires behavioral telehealth company
How to break down silos and foster collaboration across the C-suite: 3 notes
